A study of serum YKL-40 and its correlation with traditional biomarkers in rheumatoid arthritis patients

Background: This study was aimed to measure the serum levels of YKL-40 among early and late rheumatoid arthritis (RA) patients along with other disease activity measures in RA patients. Materials and Methods: It was a cross-sectional study involving 152 RA patients based on the 1987 American College...

Full description

Saved in:
Bibliographic Details
Main Authors: Vinod Narayan, Vasanthi Pallinti, Nalini Ganesan
Format: Article
Language:English
Published: SAGE Publishing 2019-01-01
Series:Indian Journal of Rheumatology
Subjects:
Online Access:http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2019;volume=14;issue=3;spage=200;epage=205;aulast=Narayan
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832544227948494848
author Vinod Narayan
Vasanthi Pallinti
Nalini Ganesan
author_facet Vinod Narayan
Vasanthi Pallinti
Nalini Ganesan
author_sort Vinod Narayan
collection DOAJ
description Background: This study was aimed to measure the serum levels of YKL-40 among early and late rheumatoid arthritis (RA) patients along with other disease activity measures in RA patients. Materials and Methods: It was a cross-sectional study involving 152 RA patients based on the 1987 American College of Rheumatology criteria for the diagnosis of RA and 68 age- and sex-matched healthy controls. The patient group was further subdivided into 75 early (<2 years disease duration) and 77 late (>2 years) RA patients based on the duration of the disease. Clinical examination was performed on RA patients, and traditional markers to measure the disease activity such as Disease Activity Score (DAS)-28, Visual Analog Score (VAS), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), anti-cyclic citrullinated peptide (CCP), and rheumatoid factor (RF) were assessed. Serum YKL-40 level was measured using ELISA method. All the values were expressed as median (25th–75th percentile). Results: In our study, there was a significant increase in serum YKL-40 level in RA patients (200.8 [141.24–282.7] ng/ml) compared to healthy controls (82.2 [49.01–123.78] ng/ml) with P < 0.001. There was no significant difference in serum YKL-40 levels among early and late RA patients. The traditional inflammatory markers such as ESR, CRP, and measures of disease activity such as DAS-28 and VAS were significantly increased in late RA patients than early RA (P < 0.001). Serum YKL-40 levels were not correlated with disease activity measures such as DAS-28, VAS, CRP, and ESR in RA patients. Conclusion: Serum YKL-40 level was significantly higher in RA. However there was no difference between early and late RA. It does not correlate with measures of disease activity.
format Article
id doaj-art-d0c4cc591b754d8f86fd8de01fc83537
institution Kabale University
issn 0973-3698
0973-3701
language English
publishDate 2019-01-01
publisher SAGE Publishing
record_format Article
series Indian Journal of Rheumatology
spelling doaj-art-d0c4cc591b754d8f86fd8de01fc835372025-02-03T10:52:11ZengSAGE PublishingIndian Journal of Rheumatology0973-36980973-37012019-01-0114320020510.4103/injr.injr_44_19A study of serum YKL-40 and its correlation with traditional biomarkers in rheumatoid arthritis patientsVinod NarayanVasanthi PallintiNalini GanesanBackground: This study was aimed to measure the serum levels of YKL-40 among early and late rheumatoid arthritis (RA) patients along with other disease activity measures in RA patients. Materials and Methods: It was a cross-sectional study involving 152 RA patients based on the 1987 American College of Rheumatology criteria for the diagnosis of RA and 68 age- and sex-matched healthy controls. The patient group was further subdivided into 75 early (<2 years disease duration) and 77 late (>2 years) RA patients based on the duration of the disease. Clinical examination was performed on RA patients, and traditional markers to measure the disease activity such as Disease Activity Score (DAS)-28, Visual Analog Score (VAS), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), anti-cyclic citrullinated peptide (CCP), and rheumatoid factor (RF) were assessed. Serum YKL-40 level was measured using ELISA method. All the values were expressed as median (25th–75th percentile). Results: In our study, there was a significant increase in serum YKL-40 level in RA patients (200.8 [141.24–282.7] ng/ml) compared to healthy controls (82.2 [49.01–123.78] ng/ml) with P < 0.001. There was no significant difference in serum YKL-40 levels among early and late RA patients. The traditional inflammatory markers such as ESR, CRP, and measures of disease activity such as DAS-28 and VAS were significantly increased in late RA patients than early RA (P < 0.001). Serum YKL-40 levels were not correlated with disease activity measures such as DAS-28, VAS, CRP, and ESR in RA patients. Conclusion: Serum YKL-40 level was significantly higher in RA. However there was no difference between early and late RA. It does not correlate with measures of disease activity.http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2019;volume=14;issue=3;spage=200;epage=205;aulast=Narayananti-cyclic citrullinated peptideearly and late rheumatoid arthritisrheumatoid arthritisrheumatoid factorykl-40
spellingShingle Vinod Narayan
Vasanthi Pallinti
Nalini Ganesan
A study of serum YKL-40 and its correlation with traditional biomarkers in rheumatoid arthritis patients
Indian Journal of Rheumatology
anti-cyclic citrullinated peptide
early and late rheumatoid arthritis
rheumatoid arthritis
rheumatoid factor
ykl-40
title A study of serum YKL-40 and its correlation with traditional biomarkers in rheumatoid arthritis patients
title_full A study of serum YKL-40 and its correlation with traditional biomarkers in rheumatoid arthritis patients
title_fullStr A study of serum YKL-40 and its correlation with traditional biomarkers in rheumatoid arthritis patients
title_full_unstemmed A study of serum YKL-40 and its correlation with traditional biomarkers in rheumatoid arthritis patients
title_short A study of serum YKL-40 and its correlation with traditional biomarkers in rheumatoid arthritis patients
title_sort study of serum ykl 40 and its correlation with traditional biomarkers in rheumatoid arthritis patients
topic anti-cyclic citrullinated peptide
early and late rheumatoid arthritis
rheumatoid arthritis
rheumatoid factor
ykl-40
url http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2019;volume=14;issue=3;spage=200;epage=205;aulast=Narayan
work_keys_str_mv AT vinodnarayan astudyofserumykl40anditscorrelationwithtraditionalbiomarkersinrheumatoidarthritispatients
AT vasanthipallinti astudyofserumykl40anditscorrelationwithtraditionalbiomarkersinrheumatoidarthritispatients
AT naliniganesan astudyofserumykl40anditscorrelationwithtraditionalbiomarkersinrheumatoidarthritispatients
AT vinodnarayan studyofserumykl40anditscorrelationwithtraditionalbiomarkersinrheumatoidarthritispatients
AT vasanthipallinti studyofserumykl40anditscorrelationwithtraditionalbiomarkersinrheumatoidarthritispatients
AT naliniganesan studyofserumykl40anditscorrelationwithtraditionalbiomarkersinrheumatoidarthritispatients